| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |